BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 14.50
0.00 (0.00%)
Jul 20, 2026, 3:59 PM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of CAD 165.86 million as of July 20, 2026. Its market cap has increased by 26.27% in one year.
Market Cap
165.86M
Enterprise Value
160.20M
Revenue
45.98M
Ranking
n/a
PE Ratio
18.49
Stock Price
14.50
ChartMarket Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 13.21M to 165.86M, an increase of 1,155.94%. That is a compound annual growth rate of 9.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 165.86M | 15.68% |
| Dec 31, 2025 | 143.37M | 12.27% |
| Dec 31, 2024 | 127.69M | 17.76% |
| Dec 29, 2023 | 108.44M | 28.05% |
| Dec 30, 2022 | 84.69M | -18.50% |
| Dec 30, 2021 | 103.91M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Auxly Cannabis Group | 258.04M |
| TerrAscend | 235.27M |
| Aurora Cannabis | 229.19M |
| Cardiol Therapeutics | 194.81M |
| Cannara Biotech | 189.66M |
| Organigram Global | 175.97M |
| Medexus Pharmaceuticals | 160.84M |
| Grown Rogue International | 154.96M |